Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
108.39
(
0.13%
)
Bitcoin
65,797.92
(
-0.24%
)
News Focus
News Focus
Post# of 257302
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

bladerunner1717

Send PM Follow Ignore
Followers 36
Posts 5652
Boards Moderated 0
Alias Born 11/09/2003

bladerunner1717

Re: DewDiligence post# 173588

Friday, 01/31/2014 5:38:15 PM

Friday, January 31, 2014 5:38:15 PM

Post# of 257302

You’ve neglected to realize that GILD’s Sovaldi + Ledipasvir regimen is de facto BID dosing for any subgroup in which ribavirin is used.

You've neglected the relapse issue and the possibility of eight week dosing.


Bladerunner
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today